Yes. Wavelength Pharmaceuticals was formerly owned by 1 private investor.
Wavelength Pharmaceuticals is headquartered in Petah Tikva, Israel.
Wavelength Pharmaceuticals is a life science company.
Ofer Park, Brosh building, 4th floor, 94 Shlomo Shmeltzer Road,
Petah Tikva,
4970602
Israel,
+972-3-577-3880
www.wavelengthpharma.com
Wavelength Pharmaceuticals is a developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Wavelength Pharmaceuticals is based in Petah Tikva, Israel.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
